日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Perioperative haemostasis with full-length, PEGylated, recombinant factor VIII with extended half-life (rurioctocog alfa pegol) in patients with haemophilia A: Final results of a multicentre, single-arm phase III trial

在A型血友病患者中,使用全长、聚乙二醇化、半衰期延长的重组因子VIII(rurioctocog alfa pegol)进行围手术期止血:一项多中心、单臂III期试验的最终结果

Gruppo, Ralph; López-Fernández, Maria-Fernanda; Wynn, Tung T; Engl, Werner; Sharkhawy, Marlies; Tangada, Srilatha

Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency

重组人透明质酸酶辅助皮下输注人免疫球蛋白治疗原发性免疫缺陷的长期耐受性、安全性和有效性

Wasserman, Richard L; Melamed, Isaac; Stein, Mark R; Engl, Werner; Sharkhawy, Marlies; Leibl, Heinz; Puck, Jennifer; Rubinstein, Arye; Kobrynski, Lisa; Gupta, Sudhir; Grant, Andrew J; Ratnayake, Anoshie; Richmond, Wendell G; Church, Joseph; Yel, Leman; Gelmont, David